請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26185
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林中梧(Chung-Wu Lin) | |
dc.contributor.author | Chien-I Chen | en |
dc.contributor.author | 陳蒨儀 | zh_TW |
dc.date.accessioned | 2021-06-08T07:02:18Z | - |
dc.date.copyright | 2011-10-07 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-08-22 | |
dc.identifier.citation | 1. Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, et al. (2001) NK cell functions restrain T cell responses during viral infections. Eur J Immunol 31: 3048-3055.
2. Soloski MJ (2001) Recognition of tumor cells by the innate immune system. Curr Opin Immunol 13: 154-162. 3. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189. 4. Takaoka A, Yanai H (2006) Interferon signalling network in innate defence. Cell Microbiol 8: 907-922. 5. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50: 1-14. 6. Bhinge AA, Kim J, Euskirchen GM, Snyder M, Iyer VR (2007) Mapping the chromosomal targets of STAT1 by Sequence Tag Analysis of Genomic Enrichment (STAGE). Genome Res 17: 910-916. 7. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R (2002) Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108: 221-232. 8. Cohen-Chalamish S, Hasson A, Weinberg D, Namer LS, Banai Y, et al. (2009) Dynamic refolding of IFN-gamma mRNA enables it to function as PKR activator and translation template. Nat Chem Biol 5: 896-903. 9. Mukhopadhyay R, Jia J, Arif A, Ray PS, Fox PL (2009) The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 34: 324-331. 10. Young HA, Bream JH (2007) IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications. Curr Top Microbiol Immunol 316: 97-117. 11. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. 12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144. 13. Caldas C, Brenton JD (2005) Sizing up miRNAs as cancer genes. Nat Med 11: 712-714. 14. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. 15. Kent OA, Mendell JT (2006) A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25: 6188-6196. 16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. 17. Djuranovic S, Nahvi A, Green R (2011) A parsimonious model for gene regulation by miRNAs. Science 331: 550-553. 18. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669. 19. Iorio R, Ciardini R, Russo A, Conteduca F, Ferretti A (2005) Reconstruction of the anterior cruciate ligament with the tendons of the semitendinosus and gracilis doubled: a comparison with reconstruction using the patellar tendon. Chir Organi Mov 90: 379-386. 20. Klingemann HG, Gong HJ, Maki G, Horsman DE, Dalal BI, et al. (1994) Establishment and characterization of a human leukemic cell line (SR-91) with features suggestive of early hematopoietic progenitor cell origin. Leuk Lymphoma 12: 463-470. 21. Maki G, Klingemann HG, Martinson JA, Tam YK (2001) Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res 10: 369-383. 22. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23. 23. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D (2005) SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686. 24. Moens U (2009) Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol 2009: 419539. 25. Purdy AK, Campbell KS (2010) Introduction of shRNAs into human NK-like cell lines with retrovirus. Methods Mol Biol 612: 223-231. 26. Miah SM, Campbell KS (2010) Expression of cDNAs in human Natural Killer cell lines by retroviral transduction. Methods Mol Biol 612: 199-208. 27. MacFarlane AWt, Oesterling JF, Campbell KS (2010) Measuring intracellular calcium signaling in murine NK cells by flow cytometry. Methods Mol Biol 612: 149-157. 28. Savan R, Chan T, Young HA (2010) Lentiviral gene transduction in human and mouse NK cell lines. Methods Mol Biol 612: 209-221. 29. Kruger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34: W451-454. 30. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26185 | - |
dc.description.abstract | 鼻之自然殺手細胞淋巴癌為與EB病毒相關且從鼻咽黏膜所引發之淋巴癌。雖然自然殺手細胞通常可以消滅被病毒感染的細胞,但目前仍尚未釐清為何病毒可以存活於自然殺手細胞中並會侵犯鄰近組織。EB病毒會轉錄出一些特定microRNA (miRNA) ,藉由這些miRNA,我們進而探討其在細胞中的調控機制。
在過去的實驗數中已知IFNγ轉譯抑制對於NK 細胞中的EB病毒影響重大。故我們利用微陣列 (micro array) 及qRT-PCR (quantitative RT-PCR) 的方式分析39個EB病毒miRNA 於EBV-positive 的YT及NK92細胞株。進而發現有12個EB病毒miRNA 於YT 細胞中的表現最為顯著, 然而在NK92細胞則未有明顯表現。並且,由於miRNA藉由與標的mRNA 3端非轉譯區 (3’ UTR) 部分或完全鹼基配對來調控轉譯進行,進而抑制標的基因的轉譯或者誘導標的mRNA的分解。為研究EB病毒的miRNA在自然殺手細胞是否會影響與IFNγ表現,首先,我們在IFNγ的3’ UTR進行9種基因依序剃除突變株,用西方墨點轉漬法 (western blot) 及螢光試驗 (luciferase assay) 在YT細胞中尋找miRNA在IFNγ的結合位。我們剔除的基因若為miRNA結合位,則western blot中 IFNγ蛋白表現或luciferase assay中的冷光表現會明顯增加。接著分析這些可能的結合位與YT細胞中表現較高的EB病毒是否相關,進而發現miR-BART20在IFNγ的3’ UTR上具結合位。並且,我們希望能建立起利用慢病毒 (lentivirus) 感染NK92細胞株的實驗系統以進一步研究miR-BART20在IFNγ的調控抑制。 | zh_TW |
dc.description.abstract | Nasal NK-cell lymphoma (NNKCL) is an Epstein-Barr virus (EBV)-associated lymphoma arising from the nasal mucosa. Because NK cells usually destroy virus-infected cells, it’s unclear how the EBV can survive in NK cells and spread to nearby tissues. Our preliminary data showed that inhibition of IFNγ translation might be a critical factor in the survival of EBV inside NK cells. Furthermore, we performed quantitative RT-PCRs for 39 EBV-encoded miRNAs. Twelve EBV-encoded miRNAs had higher expressions in IFNγ-negative YT cells than in IFNγ-positive NK92 cells, suggesting the possibility of miRNAs in the regulation of IFNγ expression. Translation of mRNAs is usually regulated by elements in the 3’ or 5’ untranslated region (3’UTR/ & 5’UTR). Therefore, we constructed IFNγ mutants to identify sites critical for translational block directed by the miRNAs in YT cells. If the IFNγ mutant site is the target site for miRNAs, translation of the mutant IFNγ would not be blocked but would be increased. We constructed 9 stepwise deletions in the 3’UTR of IFNγ. With western blotting and luciferase assay, we found out that EBV encoded miR-BART20 might potentially target 3’ UTR of IFNγ. Currently, we are using a lentiviral transduction system to express EBV-encoded miR-BART-20 in NK92 cells, and to further investigate inhibition of IFNγ by this miRNA. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T07:02:18Z (GMT). No. of bitstreams: 1 ntu-100-R98444004-1.pdf: 1571765 bytes, checksum: 989c4554130a1c4c949e689ce92547c0 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 口試委員會審定書1
誌謝2 中文摘要4 Abstract5 Introduction6 Materials and Methods10 Results23 Discussion29 References32 Figures36 Appendix49 | |
dc.language.iso | en | |
dc.title | 探討IFNγ mRNA 5端及3端非轉譯區的轉譯抑制訊息調控 | zh_TW |
dc.title | Block in the translation of IFNγ mRNA due to inhibitory signals at 5' and 3' UTRs | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃佩欣,連晃駿,廖怡華 | |
dc.subject.keyword | IFNγ,miRNA,5端非轉譯區,3端非轉譯區, | zh_TW |
dc.subject.keyword | IFNγ,miRNA, | en |
dc.relation.page | 74 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2011-08-22 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 病理學研究所 | zh_TW |
顯示於系所單位: | 病理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 1.53 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。